drugset / Trial / NCT04558216
Evaluation of Effect of Rifampin on the Pharmacokinetics of Vonoprazan in Healthy Participants
NaSingle-groupOpen-labelBasic science
Summary
The primary objective of this study is to assess the effect of multiple doses of rifampin on the pharmacokinetics of vonoprazan in healthy participants.
Timeline
- Start
- 2020-09-30
- Primary completion
- 2021-02-07
- Completion
- 2021-02-19
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Rifampin | Small molecule | 600 mg | Oral |
| Subject | Vonoprazan | Other / unclassified | 20 mg | Oral |
Indications
No indication recorded.